Clinical Evaluation of Levofloxacin Combined with Ceftriaxone Sodium in the Treatment of 30 Patients with Community-acquired Pneumonia
Abstract
Objective To evaluate the efficacy of ceftriaxone sodium combined with levofloxacin in treatment of community-acquired pneumonia(CAP).Methods 60 patients with CAP were randomly and equally divided into treatment group(ceftriaxone sodium combined with levofloxacin)and control group(single use of ceftriaxone sodium).30 patients in the treatment group received intravenous drip of ceftriaxone sodium(2 g,twice a day)and levofloxacin injection(300 mg,once a day);while the control group were only given ceftriaxone sodium intravenously(2 g,twice a day)for 10 days.Results The effective rate in the treatment group was 93.33%,significantly higher than that of control group with 73.33%(P0.05).Conclusion Ceftriaxone sodium combined with levofloxacin can significantly increase the efficiency of CAP,and improve the prognosis with good safety.
Read the paper
Related studies
- Severe clinical outcomes of COVID-19 associated with proton pump inhibitors: a nationwide cohort study with propensity score matching
- Penicillins for Treatment of Pneumococcal Pneumonia: Does In Vitro Resistance Really Matter?
- Thiophenes—Naturally Occurring Plant Metabolites: Biological Activities and In Silico Evaluation of Their Potential as Cathepsin D Inhibitors
- Inhalable Mannosylated Rifampicin–Curcumin Co-Loaded Nanomicelles with Enhanced In Vitro Antimicrobial Efficacy for an Optimized Pulmonary Tuberculosis Therapy
- Development and validation of microbial bioassay for quantification of Levofloxacin in pharmaceutical preparations
- Association between cord blood 25-hydroxyvitamin D concentrations and respiratory tract infections in the first 6 months of age in a Korean population: a birth cohort study (COCOA)
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.